Abiopharma

🔍 KAO JOHN E (Director)

Company: Alignment Healthcare, Inc. (ALHC)

Report Date: 2026-03-18

Detailed Transactions and Holdings:

• Sold 73,046 shares of Common Stock at $17.84 per share (Direct)
  Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,784,868.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 2,472,641.00 | Footnotes: F3

Footnotes:

• F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
• F2: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
• F3: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.